These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7566279

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.
    Goodkin DE, Rudick RA, VanderBrug Medendorp S, Daughtry MM, Schwetz KM, Fischer J, Van Dyke C.
    Ann Neurol; 1995 Jan; 37(1):30-40. PubMed ID: 7818255
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Guidelines for drug treatment of multiple sclerosis].
    Kollegger H, Vass K, Marschall I, Koch G, Deecke L.
    Wien Klin Wochenschr; 1993 Jan; 105(16):443-52. PubMed ID: 7692677
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of multiple sclerosis and other autoimmune diseases with cladribine.
    Beutler E, Sipe J, Romine J, McMillan R, Zyroff J, Koziol J.
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):45-52. PubMed ID: 8714617
    [No Abstract] [Full Text] [Related]

  • 10. [New immunomodulator for multiple sclerosis patients. 30% fewer relapse rates].
    MMW Fortschr Med; 2002 May 06; Suppl 2():88. PubMed ID: 12070870
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Methotrexate pneumonitis precipitated by switching from oral to parenteral administration.
    Collins K, Aspey H, Todd A, Saravanan V, Rynne M, Kelly C.
    Rheumatology (Oxford); 2008 Jan 06; 47(1):109-10. PubMed ID: 18042567
    [No Abstract] [Full Text] [Related]

  • 14. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
    Metzler C, Miehle N, Manger K, Iking-Konert C, de Groot K, Hellmich B, Gross WL, Reinhold-Keller E, German Network of Rheumatic Diseases.
    Rheumatology (Oxford); 2007 Jul 06; 46(7):1087-91. PubMed ID: 17519271
    [Abstract] [Full Text] [Related]

  • 15. Natalizumab: bound to rebound?
    Schiess N, Calabresi PA.
    Neurology; 2009 Feb 03; 72(5):392-3. PubMed ID: 19188569
    [No Abstract] [Full Text] [Related]

  • 16. [Current therapy of multiple sclerosis: mitoxantrone].
    Spuler S, Hohlfeld R.
    Nervenarzt; 1994 Feb 03; 65(2):136-8. PubMed ID: 8164768
    [No Abstract] [Full Text] [Related]

  • 17. [Comments on the contribution, "Immunomodulating staged therapy of multiple sclerosis by the Multiple Sclerosis Therapy Consensus Group"].
    Störh M.
    Nervenarzt; 2002 Dec 03; 73(12):1207; author reply 1207. PubMed ID: 12599336
    [No Abstract] [Full Text] [Related]

  • 18. Reversible impaired memory induced by pulsed methylprednisolone in patients with MS.
    Uttner I, Müller S, Zinser C, Maier M, Süssmuth S, Claus A, Ostermann B, Elitok E, Ecker D, Brettschneider J, Gold R, Tumani H.
    Neurology; 2005 Jun 14; 64(11):1971-3. PubMed ID: 15955958
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effects of low dose methotrexate therapy in rheumatoid arthritis: a comparison of three different dosage regimens].
    Totokawa S, Furuya T, Nakajima A, Suzuki T, Kashiwazaki S.
    Ryumachi; 1997 Oct 14; 37(5):681-7. PubMed ID: 9396370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.